CAPTRUST FINANCIAL ADVISORS - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$6,000
+20.0%
1,3940.0%0.00%
Q1 2022$5,0000.0%1,394
-6.6%
0.00%
Q4 2021$5,0000.0%1,493
-1.3%
0.00%
Q3 2021$5,000
-16.7%
1,512
+1.4%
0.00%
Q2 2021$6,000
-25.0%
1,491
-1.4%
0.00%
Q1 2021$8,000
-38.5%
1,512
+51.2%
0.00%
Q4 2020$13,000
+30.0%
1,0000.0%0.00%
Q3 2020$10,0000.0%1,0000.0%0.00%
Q2 2020$10,000
+233.3%
1,000
+400.0%
0.00%
Q4 2018$3,0002000.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,420,349$25,814,8383.96%
Parkman Healthcare Partners LLC 1,203,484$7,028,3471.87%
SPHERA FUNDS MANAGEMENT LTD. 1,002,783$5,856,2531.26%
TANG CAPITAL MANAGEMENT LLC 1,150,000$6,716,0000.98%
BVF INC/IL 3,629,000$21,193,3600.89%
Nantahala Capital Management 1,732,388$10,117,1460.66%
AWM Investment Company, Inc. 666,661$3,893,3000.56%
INGALLS & SNYDER LLC 1,295,833$7,5680.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 200,800$1,172,6720.36%
Kensington Investment Counsel, LLC 58,599$342,2180.27%
View complete list of CONCERT PHARMACEUTICALS INC shareholders